Yumanity Therapeutics Inc
YMTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.72M
Close$
Share Statistics
| Market cap | $15.72 Million |
|---|---|
| Enterprise Value | $20.93 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.42 |
| Beta | 0 |
| Outstanding Shares | 12,902,000 |
Return
| Return on Equity | 58.35% |
|---|---|
| Return on Assets | -914.25% |
| Return on Invested Capital | 64.34% |
Valuation & Multiples
| P/E Ratio | -2.24 |
|---|---|
| PEG | 2.68 |
| Price to Sales | - |
| Price to Book Ratio | -0.95 |
| Enterprise Value to Revenue | 4.83 |
| Enterprise Value to EBIT | -2.47 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | -0.42 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Yumanity Therapeutics Inc
CEO: Meenu Chhabra